Navigation Links
Beta carotene and retinitis pigmentosa
Date:10/18/2010

CHICAGOToday's Scientific Program of the 2010 American Academy of Ophthalmology (AAO) - Middle East-Africa Council of Ophthalmology (MEACO) Joint Meeting includes a report on beta carotene's ability to improve vision in people with certain incurable retinal diseases. The AAO-MEACO meetingthe world's largest, most comprehensive ophthalmic education conferenceis in session October 16 through 19 at McCormick Place, Chicago.

9-cis Beta-Carotene Mat Boost Vision in Some Patients with Incurable Retinal Disease Retinitis pigmentosa (RP) is a cluster of hereditary disorders of the retina (the light-sensitive tissue at the back of the eye) that can result in incurable blindness. RP usually begins with night blindness in childhood, then loss of peripheral (side) vision leading to tunnel vision, and ultimately blindness. Since a specific form of the nutrient beta carotene, 9-cis, has been effective against one type of night blindness, researchers decided to test its effects in RP patients. One third of the 29 participating patients showed improved visual function while taking the prescribed oral dose for 90 days, but the other two-thirds showed no effect.

"We recommend repeating the study with patients with the genetic forms of RP that would be most likely to respond to oral beta carotene," said Dr. Rotensteich. "We know its positive effect is associated with retinoid cycle defect, which is involved in some but not all forms of RP. Also, future research should look for the optimal beta carotene dosage," he added.


'/>"/>

Contact: Mary Wade
mwade@aao.org
510-725-5677
American Academy of Ophthalmology
Source:Eurekalert

Page: 1

Related biology news :

1. Iowa State study finds corn bred to contain beta-carotene is a good source of vitamin A
2. Vitamins C and E and beta carotene again fail to reduce cancer risk in randomized controlled trial
3. Valproic acid shown to halt vision loss in patients with retinitis pigmentosa
4. OU researchers find way to prevent blindness in research model for retinitis pigmentosa
5. Stem cells restore sight in mouse model of retinitis pigmentosa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 /PRNewswire/ ... product subsidiary of Infosys (NYSE: INFY ), and ... global partnership that will provide end customers with ... banking and payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ... area for financial services, but it also plays a fundamental ...
(Date:4/28/2016)... GOTHENBURG, Sweden , April 28, 2016 ... 1,491.2 M (139.9), up 966% compared with the first quarter of ... Operating profit totaled SEK 589.1 M (loss: 18.8) and the operating ... SEK 7.12 (loss: 0.32) Cash flow from operations was ... , The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/26/2016)... and LONDON , April ... part of EdgeVerve Systems, a product subsidiary of ... today announced a partnership to integrate the Onegini ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... their customers enhanced security to access and transact ...
Breaking Biology News(10 mins):
(Date:4/27/2016)... British Columbia , April 27, 2016 /PRNewswire/ ... oder "NanoStruck") (CSE: NSK) (OTCPink: NSKQB) ( ... im Anschluss an ihre Pressemitteilung vom 13. August ... erhalten hat, ihre Finanzen um zusätzliche 200.000.000 Einheiten ... 4.000.000 Kanadische Dollar zu bringen. Davon wurden 157.900.000 ...
(Date:4/27/2016)... , ... April 27, 2016 , ... ... is pleased to announce the appointment of John Tilton as Chief Commercial Officer.  ... Director and one of the founding commercial leaders responsible for the commercialization of ...
(Date:4/27/2016)... ... April 27, 2016 , ... ... to its Scientific Advisory Board. Dr. Lamka will assist PathSensors in expanding the ... , PathSensors deploys the CANARY® test platform for the detection of harmful ...
(Date:4/27/2016)... ... 2016 , ... Global Stem Cells Group CEO Benito Novas announced ... of GSCG affiliate Kimera Labs in Miami. , In 2004, Ross received his Ph.D. ... for hematologic disorders and the suppression of graft vs. host disease (GVHD) under UM ...
Breaking Biology Technology: